# SLM Corp: overview SLM · Nasdaq · CIK 1032033 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/slm.md) · [Financials](/companies/slm/financials.md) · [Filings](/companies/slm/filings.md) · [Insiders](/companies/slm/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | not reported | [1.40](/filings/0001032033-26-000025.md) | [0.32](/filings/0001032033-26-000042.md) | [0.63](/filings/0001032033-26-000052.md) | not reported | [1.54](/filings/0001032033-26-000025.md) | [0.29](/filings/0001032033-26-000042.md) | [(0.19)](/filings/0001032033-26-000052.md) | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [3.61](/filings/0001628280-24-006382.md) | [1.76](/filings/0001628280-25-006776.md) | [2.41](/filings/0001032033-26-000011.md) | [2.68](/filings/0001032033-26-000011.md) | [3.46](/filings/0001032033-26-000011.md) | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/slm/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $455.6m | 17,562,699 | | Reduced −1,318,111 | | [FMR LLC](/funds/315066.md) | 2026-06-30 | $442.3m | 17,052,007 | | Reduced −864,462 | | [Brave Warrior Advisors, LLC](/funds/1553733.md) | 2026-06-30 | $347.1m | 13,381,145 | | Reduced −203,223 | | [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $249.6m | 9,621,467 | | Reduced −1,205,662 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $212.7m | 8,198,835 | | Reduced −364,988 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $204.9m | 7,898,402 | | Added +383,372 | | [HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC](/funds/1164833.md) | 2026-06-30 | $187.2m | 7,216,318 | | Added +730,130 | | [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $186.9m | 7,206,261 | | Added +890,666 | | [BARROW HANLEY MEWHINNEY & STRAUSS LLC](/funds/313028.md) | 2026-06-30 | $169.1m | 6,520,274 | | Added +1,289,315 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $168.9m | 6,510,300 | | Added +58,070 | ## Recent filings [All 1,647 filings](/companies/slm/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-22 | 16:33 ET | [10-Q](/filings/0001032033-26-000052.md) | Quarterly report, period 2026-09-30 | 0001032033-26-000052 | | 2026-10-22 | 16:32 ET | [8-K](/filings/0001032033-26-000051.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001032033-26-000051 | | 2026-08-05 | 16:30 ET | [8-K](/filings/0001032033-26-000046.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001032033-26-000046 | | 2026-07-23 | 16:33 ET | [10-Q](/filings/0001032033-26-000042.md) | Quarterly report, period 2026-06-30 | 0001032033-26-000042 | | 2026-07-23 | 16:32 ET | [8-K](/filings/0001032033-26-000041.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001032033-26-000041 | | 2026-06-18 | 16:30 ET | [8-K](/filings/0001032033-26-000036.md) | 5.07 Shareholder vote results | 0001032033-26-000036 | | 2026-06-10 | 07:00 ET | [8-K](/filings/0001032033-26-000034.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001032033-26-000034 | | 2026-05-15 | 10:37 ET | [8-K](/filings/0001193125-26-225683.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-225683 | | 2026-05-06 | 09:03 ET | [8-K](/filings/0001193125-26-207711.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-207711 | | 2026-05-05 | 16:31 ET | [8-K](/filings/0001032033-26-000031.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001032033-26-000031 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001032033-26-000011.md), filed Feb 19, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1032033 - Tickers: SLM, SLMBP - Exchange: Nasdaq - SIC code: 6141 Personal Credit Institutions - State of incorporation: DE - Filer category: Large accelerated filer Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 13:54 ET. No prices; not investment advice.